Sana Biotechnology, Inc. (SANA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Core Insights - The company is focused on addressing two significant challenges in the field of cell and gene therapy, aiming to make these therapies more actionable and impactful for broader applications [1]. Group 1 - The company has been working on strategies to hide transplanted cells from immune recognition, which has been a longstanding challenge in transplant medicine [2].